Filing Details

Accession Number:
0001415889-24-017054
Form Type:
4
Zero Holdings:
No
Publication Time:
2024-06-17 07:29:53
Reporting Period:
2024-06-13
Accepted Time:
2024-06-17 07:29:53
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1810182 Alx Oncology Holdings Inc ALXO () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1188956 S Peter Garcia C/O Alx Oncology Holdings Inc.
323 Allerton Avenue
South San Francisco CA 94080
Chief Financial Officer No No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2024-06-13 12,000 $8.53 122,348 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Footnotes
  1. The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $8.4113 to $8.68, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price.